Ana Macedo Pereira graduated in Bioengineering and completed her master's degree in Molecular Bioengineering (2022) from the Faculty of Engineering of the University of Porto. 

During her course in Bioengineering, Ana had the opportunity to perform several internships related to biomaterials and nanotechnology. Posteriorly, Ana did her master's dissertation at Associated Laboratory for Green Chemistry of the Network of Chemistry and Technology (LAQV/REQUIMTE). .

Ana is enrolled in the Biomedical Sciences Doctoral Program at the Cooperativa de Ensino Superior Politécnico e Universitário (CESPU, CRL), under the supervision of Bruno Sarmento, group leader of "Nanomedicines & Translational Drug Delivery", and Jorge Lima from the group "Cancer Signalling & Metabolism" at Instituto de Investigação e Inovação em Saúde (i3S). 

Currently, her work focuses on designing effective nanomedicines to target recurrent glioblastoma and its metabolic impact.